AGI-14100
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Product Specifications
CAS Number
1448346-43-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
599.96
Molecular Formula
C29H22ClF4N5O3
Notes
Research use only, not for human use.
Receptor
Dehydrogenase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2717905 3x 1.0 µg
ZNF593 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details TA801365 100 µL
NM23A (NME1) Mouse Monoclonal Antibody [Clone ID: OTI4F11]
Sign In for Pricing
View Details 
BNC742743-100 1x 100 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PB9964-Dylight488 100 µg
Anti-WNK1 Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details 
K3511304 1.0 µg DNA
Dcxr sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details